How GLP-1 medications compare to bariatric surgery
For most of my career as a bariatric surgeon, I told patients that surgery was the most reliable tool we had for significant, sustained weight loss. That conversation has fundamentally changed.
In the past three years, GLP-1 receptor agonists, a class of medications originally developed for type 2 diabetes, have redefined what is medically achievable for patients with obesity. As someone who has performed hundreds of bariatric procedures and now helps …
How GLP-1 medications compare to bariatric surgery
